| Breakdown | TTM | Mar 2025 | Mar 2024 | Dec 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.38M | 20.90M | 14.43M | 19.68M | 13.49M | 4.94M |
| Gross Profit | 5.44M | 7.02M | 2.56M | 7.19M | 8.41M | 2.13M |
| EBITDA | 11.59M | 12.05M | 57.75K | 8.78M | 11.81M | -5.22M |
| Net Income | 2.06M | 4.00M | -5.37M | 4.71M | 8.95M | -7.56M |
Balance Sheet | ||||||
| Total Assets | 50.86M | 37.06M | 29.74M | 21.61M | 16.28M | 10.89M |
| Cash, Cash Equivalents and Short-Term Investments | 15.10M | 1.02M | 7.11M | 2.10M | 1.66M | 713.46K |
| Total Debt | 27.14M | 15.03M | 9.09M | 203.26K | 253.03K | 3.84M |
| Total Liabilities | 33.73M | 21.48M | 18.16M | 4.66M | 4.15M | 7.70M |
| Stockholders Equity | 17.13M | 15.58M | 11.58M | 16.95M | 12.14M | 3.19M |
Cash Flow | ||||||
| Free Cash Flow | 6.46M | -6.82M | -6.06M | 5.11M | 4.72M | -2.41M |
| Operating Cash Flow | 10.77M | 10.25M | 5.86M | 11.66M | 8.05M | 1.54M |
| Investing Cash Flow | -12.44M | -15.28M | -14.94M | -12.87M | -2.90M | -5.69M |
| Financing Cash Flow | 11.84M | 5.94M | 8.90M | 52.50K | -3.81M | 3.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | C$13.23M | 180.90 | 12.30% | ― | 16.71% | ― | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
50 Neutral | C$12.03M | -1.71 | -36.60% | ― | 295.02% | 78.28% | |
49 Neutral | C$14.56M | -4.39 | -18.37% | ― | -32.11% | 66.67% | |
45 Neutral | C$10.80M | -4.61 | 431.16% | ― | ― | ― | |
44 Neutral | C$9.05M | -0.40 | -575.47% | ― | ― | -920.00% | |
41 Neutral | C$10.15M | -3.53 | -43.43% | ― | ― | -1150.00% |